New York Life Investment Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-112,568
Closed -$8.51M 804
2026
Q1
$8.51M Buy
112,568
+14,329
+15% +$1.08M 0.07% 230
2025
Q4
$7.32M Buy
98,239
+67,874
+224% +$4.96M 0.06% 247
2025
Q3
$2.05M Sell
30,365
-3,165
-9% -$210K 0.02% 540
2025
Q2
$2.18M Sell
33,530
-158
-0.5% -$9.47K 0.02% 515
2025
Q1
$2.08M Sell
33,688
-1,324
-4% -$87.7K 0.02% 533
2024
Q4
$2.52M Buy
35,012
+361
+1% +$28.2K 0.02% 500
2024
Q3
$2.82M Sell
34,651
-2,443
-7% -$195K 0.03% 490
2024
Q2
$2.75M Buy
37,094
+1,313
+4% +$98.4K 0.03% 472
2024
Q1
$2.79M Sell
35,781
-2,742
-7% -$204K 0.03% 471
2023
Q4
$2.75M Buy
38,523
+257
+0.7% +$17.9K 0.03% 467
2023
Q3
$2.66M Sell
38,266
-412
-1% -$31.1K 0.03% 435
2023
Q2
$3.13M Sell
38,678
-239
-0.6% -$19.5K 0.03% 406
2023
Q1
$3.14M Sell
38,917
-484
-1% -$39K 0.03% 405
2022
Q4
$2.95M Sell
39,401
-4
-0% -$285 0.03% 435
2022
Q3
$2.54M Sell
39,405
-202
-0.5% -$14K 0.03% 457
2022
Q2
$2.75M Buy
+39,607
New +$2.94M 0.03% 431

Other funds holding HOLX

New York Life Investment Management's HOLX Position: Q2 2026 in Review

New York Life Investment Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 112,568 shares — an estimated $8.51M sold.

New York Life Investment Management first reported a position in HOLX in Q2 2022 and held it in 16 quarters. The position peaked at $8.51M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • New York Life Investment Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • New York Life Investment Management sold 112,568 Hologic shares in Q2 2026, an estimated $8.51M.
  • New York Life Investment Management first reported a position in Hologic in Q2 2022 and held it in 16 quarters.
  • New York Life Investment Management's Hologic position peaked at $8.51M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.